<DOC>
	<DOCNO>NCT01749644</DOCNO>
	<brief_summary>Pseudomonas common virulent respiratory bacteria patient Cystic Fibrosis ( CF ) . With time , infection Pseudomonas become chronic difficult eradicate . The standard treatment chronic Pseudomonas infection inhale Tobramycin give every month.. Inhalation Tobramycin proven effective treatment improve respiratory function reduces concentration bacteria sputum . However , inhale treatment last 15 30 minute twice day therefore adherence major problem . The effect switch inhalation treatment inhaler treatment patient 's adherence quality life study .</brief_summary>
	<brief_title>Switching From Tobramycin Inhalation Treatment Tobramycin Inhaler Treatment : The Effect CF Patients ' Adherence Quality Life</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>Age 6 year , Chronic Pseudomonas infection Younger 6 year ; No chronic PSeudomonas infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Cystic Fibrosis , Chronic Pseudomonas Infection , Inhaled Tobramycin</keyword>
</DOC>